Post stationary telemedical care of patients with severe psychiatric disorders

Conditions

F20 F25.SCHIZOAFFEKTIVESTOERUNGEN F31.BIPOLARESTOERUNGEN

Stentzel U, van den Berg N, Moon K, Schulze LN, Schulte J, Langosch JM, Hoffmann W, Grabe HJ.

2021-06-297 citations

Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla).

Stentzel U, van den Berg N, Schulze LN, Schwaneberg T, Radicke F, Langosch JM, Freyberger HJ, Hoffmann W, Grabe HJ.

2018-05-2946 citations

10.1186/s12888-018-1737-4

Tecla: a telephone- and text-message based telemedical concept for patients with severe mental health disorders--study protocol for a controlled, randomized, study.

Stentzel U, Grabe HJ, Strobel L, Penndorf P, Langosch J, Freyberger HJ, Hoffmann W, van den Berg N.

2015-11-049 citations

10.1186/s12888-015-0659-7

Interventions

Group 1: Intervention group: All subjects received a baseline interview. It assess among others the medication adherence with MARS-D, but also the quality of life (WHOQOL). Intervention: Every two wee

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Medical diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder. Signed consent to study participation.

Exclusion criteria

Exclusion criteria: Planned hospitalization in the next 6 months. No telephone access.

Design outcomes

Primary

Measure	Time frame
The primary endpoint is the evaluation medication adherence. The assesssment instrument is the MARS-D (German version of the Medication Adherence Report Scale). Times of measurement are baseline, 3- and 6-months-follow ups. The hypothesis is that after 6 months, the medication adherence in the intervention group is better than the control group.	—

Secondary

Measure	Time frame
Secondary endpoints compare the frequency of anew and unplanned psychiatric (partly) inpatient stays, the periods until the unplanned (partly) inpatient treatment as well as quality of life, coping with everyday life and the development of symptoms within each of the 6 months. Data of unplannend readmissions are recorded with computer assistance. The quality of life is measured by the questionnaire WHOQOL-BREF (World Health Organsiation Quality Of Life), coping with everyday life with GAF (Global Assessment of Functioning) and symptoms with BPRS (Brief Psychiatric Rating Scale). Measurement times are baseline, 3- and 6-month follow-ups.	—

Measure

Time frame

Secondary endpoints compare the frequency of anew and unplanned psychiatric (partly) inpatient stays, the periods until the unplanned (partly) inpatient treatment as well as quality of life, coping with everyday life and the development of symptoms within each of the 6 months. Data of unplannend readmissions are recorded with computer assistance. The quality of life is measured by the questionnaire WHOQOL-BREF (World Health Organsiation Quality Of Life), coping with everyday life with GAF (Global Assessment of Functioning) and symptoms with BPRS (Brief Psychiatric Rating Scale). Measurement times are baseline, 3- and 6-month follow-ups.

—

Countries

Germany

Contacts

Public ContactNeeltje van den Berg

Universitätsmedizin GreifswaldInstitut für Community Medicine

neeltje.vandenberg@uni-greifswald.de03834-867771

Outcome results

None listed